TT Electronics announced that it has been working with British start-up iAbra, and its partners, including Intel, to design, develop, and test the prototype Virolens system and to specify and design the manufacturing processes for its commercial launch.

The Virolens system, which according to the company provides test results for COVID-19 in 20 seconds, has been launched following successful trials at London Heathrow Airport over recent weeks. The Virolens COVID-19 screening device uses microscopic holographic imaging and artificial intelligence (AI) software technology to detect the presence of the COVID-19 virus from a non-intrusive saliva swab test within 20 seconds. According to the company, the device does not need to be administered by healthcare professionals and is expected to be used in airports, offices, sports venues, and other locations where people are in close proximity to each other.

TT has been appointed exclusive manufacturing partner for the commercial launch of Virolens, which incorporates several TT proprietary products. Working in collaboration with iAbra and the global supply chain, TT has taken the product from concept to production in just 14 weeks.

TT will manufacture Virolens at its Hartlepool, UK facility, part of its Power and Connectivity division, for this launch phase. Initial orders for devices and testing cartridges which will be delivered to potential launch customers in September and October 2020 total a value of circa £2 million, and opportunity from expressions of interest could reach £280 million in the next 12 months.

Delivery of these further orders could commence in Q4 2020 and would continue into 2021.

For more information, visit: https://www.ttelectronics.com/